P&G reports fiscal 2026 sales of $87.0 billion, Q4 diluted EPS down 15%
AI Market Summary
P&G reported FY26 net sales up 3% (organic +1%) but Q4 organic sales were flat and profitability weakened, with core EPS down 3% and diluted EPS down 15% as gross margin compressed and SG&A rose. Management guided FY27 for 1–3% sales and organic growth, while flagging a sizable cost and FX headwind and ongoing restructuring charges. The mix signals steady demand but near-term margin pressure.
Impact level
● Medium
Affected assets
NCSKPG2USD/USDT+0.00%
AI Insight · NCSKPG2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Procter & Gamble reported fiscal 2026 fourth-quarter and full-year results, with Q4 organic sales flat and core EPS down 3% year over year while diluted EPS fell 15%. For the full fiscal year, organic sales rose 1% and core EPS increased 1%. The company posted $87.0 billion in revenue, supported primarily by favorable foreign exchange effects and higher pricing. A narrower gross margin and higher SG&A expenses weighed on profitability.
